Oncologist 2019 Apr
Initial Report of Second-Line FOLFIRI in Combination with Ramucirumab in Advanced Gastroesophageal Adenocarcinomas: A Multi-Institutional Retrospective Analysis.
Related Questions
New answer by Medical Oncologist at Memorial Sloan Kettering Cancer Center (April 1, 2022)
As we all know, peri-operative FLOT is considered a standard-of-care for locally advanced GEJ/gastric adenocarcinomas (at least the vast majority of tumors that are MMR profic...